| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.09B | 906.85M | 705.75M | 534.70M | 476.40M |
| Gross Profit | 147.69M | 141.84M | 133.11M | 83.38M | 128.59M |
| EBITDA | 66.92M | 67.64M | 76.03M | 29.39M | 53.20M |
| Net Income | 54.80M | 51.30M | 43.58M | 22.32M | 35.23M |
Balance Sheet | |||||
| Total Assets | 1.93B | 1.69B | 1.39B | 1.15B | 933.76M |
| Cash, Cash Equivalents and Short-Term Investments | 136.15M | 33.90M | 32.47M | 53.74M | 26.50M |
| Total Debt | 705.39M | 640.75M | 712.97M | 638.51M | 360.40M |
| Total Liabilities | 1.32B | 1.25B | 979.45M | 775.84M | 553.99M |
| Stockholders Equity | 597.86M | 447.03M | 409.18M | 372.64M | 377.76M |
Cash Flow | |||||
| Free Cash Flow | -134.41M | 87.26M | -80.23M | -119.92M | -124.46M |
| Operating Cash Flow | -76.62M | 191.69M | 30.00M | 41.86M | 6.44M |
| Investing Cash Flow | -57.55M | -133.17M | -139.95M | -157.54M | -110.16M |
| Financing Cash Flow | 139.05M | -44.65M | 94.22M | 142.02M | 68.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$518.45M | 11.45 | 6.48% | 8.33% | -11.73% | -69.83% | |
73 Outperform | HK$367.40M | 3.03 | 20.13% | ― | -1.25% | -36.93% | |
72 Outperform | HK$289.30M | 9.71 | 3.92% | 10.32% | 2.75% | -21.60% | |
70 Outperform | HK$280.01M | 16.57 | 5.40% | 6.41% | -34.28% | -45.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | HK$363.93M | 6.45 | 10.20% | ― | 23.29% | 9.11% | |
41 Neutral | HK$461.31M | -10.12 | 358.39% | ― | -45.11% | -48.30% |